Hexima’s (ASX:HXL) shares take a hit on pezadeftide results
Clinical stage biotech company Hexima (HXL) has decided not to proceed with…
Hexima Limited. (ASX:HXL)
About Hexima Limited.
Key Information
HXL In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 22/03/2024 | Receipt of R&D Tax Refund | 107.45KB | 760 |
| 20/03/2024 | Change of Director's Interest Notice - Mr Geoffrey Kempler | 170.94KB | 128 |
| 20/03/2024 | Notification regarding unquoted securities - HXL | 18.51KB | 120 |
| 19/03/2024 | Change of Address | 107.42KB | 125 |
| 29/02/2024 | Price Sensitive PS Appendix 4D and Interim Financial Report | 808.19KB | 203 |
| 01/02/2024 | Notification of cessation of securities - HXL | 24.17KB | 202 |
| 31/01/2024 | Price Sensitive PS Business Activity Statement & Appendix 4C - Dec-2023 Qtr | 1.05MB | 240 |
| 01/12/2023 | Final Director's Interest Notice - Dr Nicole van der Weerden | 185.88KB | 200 |